Results 1 to 10 of about 237,068 (156)

Enantioselective Drug Recognition by Drug Transporters [PDF]

open access: yesMolecules, 2018
Drug transporters mediate the absorption, tissue distribution, and excretion of drugs. The cDNAs of P-glycoprotein, multidrug resistance proteins (MRPs/ABCC), breast cancer resistance protein (BCRP/ABCG2), peptide transporters (PEPTs/SLC15), proton ...
Yuichi Uwai
doaj   +3 more sources

Regulation of CYP450 and drug transporter mediated by gut microbiota under high-altitude hypoxia [PDF]

open access: yesFrontiers in Pharmacology, 2022
Hypoxia, an essential feature of high-altitude environments, has a significant effect on drug metabolism. The hypoxia–gut microbiota–CYP450/drug transporter axis is emerging as a vital factor in drug metabolism.
Xue Bai   +9 more
doaj   +2 more sources

A Literature Review of Changes in Phase II Drug-Metabolizing Enzyme and Drug Transporter Expression during Pregnancy [PDF]

open access: yesPharmaceutics, 2023
The purpose of this literature review is to comprehensively summarize changes in the expression of phase II drug-metabolizing enzymes and drug transporters in both the pregnant woman and the placenta.
Christine Gong   +3 more
doaj   +2 more sources

Emerging transporter-targeted nanoparticulate drug delivery systems

open access: yesActa Pharmaceutica Sinica B, 2019
Transporter-targeted nanoparticulate drug delivery systems (nano-DDS) have emerged as promising nanoplatforms for efficient drug delivery. Recently, great progress in transporter-targeted strategies has been made, especially with the rapid developments ...
Hongyan Su   +6 more
doaj   +3 more sources

Kidney Ischemia/Reperfusion Injury Induces Changes in the Drug Transporter Expression at the Blood–Brain Barrier in vivo and in vitro [PDF]

open access: yesFrontiers in Physiology, 2020
Ischemia/reperfusion injury is a major cause of acute kidney injury (AKI). AKI is characterized by a sudden decrease in kidney function, systemic inflammation, oxidative stress, and dysregulation of the sodium, potassium, and water channels.
Malgorzata Burek   +7 more
doaj   +2 more sources

Drug transporter mRNA expression and genital inflammation in South African women on oral pre-exposure prophylaxis (PrEP) [PDF]

open access: yesAIDS Research and Therapy
Globally HIV remains a major public health problem. In sub-Saharan Africa most new HIV infections occur in adolescent girls and young women. Previously tested antiretroviral drugs as different pre-exposure prophylaxis (PrEP) formulations have shown ...
Nomusa M. Zondo   +9 more
doaj   +2 more sources

Imbalance of Drug Transporter-CYP450s Interplay by Diabetes and Its Clinical Significance [PDF]

open access: yesPharmaceutics, 2020
The pharmacokinetics of a drug is dependent upon the coordinate work of influx transporters, enzymes and efflux transporters (i.e., transporter-enzyme interplay). The transporter–enzyme interplay may occur in liver, kidney and intestine.
Yiting Yang, Xiaodong Liu
doaj   +2 more sources

Transporter-Mediated Drug–Drug Interactions with Oral Antidiabetic Drugs

open access: yesPharmaceutics, 2011
Uptake transporters (e.g., members of the SLC superfamily of solute carriers) and export proteins (e.g., members of the ABC transporter superfamily) are important determinants for the pharmacokinetics of drugs.
Jörg König   +2 more
doaj   +3 more sources

Mechanistic in vitro studies indicate that the clinical drug–drug interactions between protease inhibitors and rosuvastatin are driven by inhibition of intestinal BCRP and hepatic OATP1B1 with minimal contribution from OATP1B3, NTCP and OAT3

open access: yesPharmacology Research & Perspectives, 2023
Previous use of a mechanistic static model to accurately quantify the increased rosuvastatin exposure due to drug–drug interaction (DDI) with coadministered atazanavir underpredicted the magnitude of area under the plasma concentration–time curve ratio ...
Robert Elsby   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy